Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27152426
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27152426
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 PLoS+Genet
2016 ; 12
(5
): e1006031
Nephropedia Template TP
Riaz M
; Raz Y
; van Putten M
; Paniagua-Soriano G
; Krom YD
; Florea BI
; Raz V
PLoS Genet
2016[May]; 12
(5
): e1006031
PMID27152426
show ga
Poly(A) Binding Protein Nuclear 1 (PABPN1) is a multifunctional regulator of mRNA
processing, and its expression levels specifically decline in aging muscles. An
expansion mutation in PABPN1 is the genetic cause of oculopharyngeal muscle
dystrophy (OPMD), a late onset and rare myopathy. Moreover, reduced PABPN1
expression correlates with symptom manifestation in OPMD. PABPN1 regulates
alternative polyadenylation site (PAS) utilization. However, the impact of PAS
utilization on cell and tissue function is poorly understood. We hypothesized
that altered PABPN1 expression levels is an underlying cause of muscle wasting.
To test this, we stably down-regulated PABPN1 in mouse tibialis anterior (TA)
muscles by localized injection of adeno-associated viruses expressing shRNA to
PABPN1 (shPab). We found that a mild reduction in PABPN1 levels causes muscle
pathology including myofiber atrophy, thickening of extracellular matrix and
myofiber-type transition. Moreover, reduced PABPN1 levels caused a consistent
decline in distal PAS utilization in the 3'-UTR of a subset of OPMD-dysregulated
genes. This alternative PAS utilization led to up-regulation of Atrogin-1, a key
muscle atrophy regulator, but down regulation of proteasomal genes. Additionally
reduced PABPN1 levels caused a reduction in proteasomal activity, and transition
in MyHC isotope expression pattern in myofibers. We suggest that PABPN1-mediated
alternative PAS utilization plays a central role in aging-associated muscle
wasting.